C2i, a genomics SaaS product to detect traces of cancer, raises $100M Series B

17:00 15.04.2021
If you or a loved one has ever undergone a tumor removal as part of cancer treatment, you’re likely familiar with the period of uncertainty and fear that follows. Will the cancer return, and if so, will the doctors catch it at an early enough stage? C2i Genomics has developed software that’s 100x more sensitive […]...
  342